Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,500 | 7 | 38.9% |
| Honoraria | $10,500 | 6 | 24.8% |
| Travel and Lodging | $7,206 | 30 | 17.0% |
| Consulting Fee | $5,417 | 4 | 12.8% |
| Food and Beverage | $2,735 | 45 | 6.5% |
| Education | $28.83 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $35,179 | 66 | $0 (2020) |
| Rockwell Medical, Inc. | $3,357 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,114 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $352.36 | 3 | $0 (2022) |
| CALLIDITAS THERAPEUTICS US INC. | $249.51 | 2 | $0 (2024) |
| Penumbra, Inc. | $154.18 | 1 | $0 (2017) |
| Vifor Pharma, Inc. | $131.78 | 2 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $129.21 | 2 | $0 (2022) |
| Relypsa, Inc. | $119.15 | 1 | $0 (2019) |
| Baxter Healthcare | $117.76 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $575.16 | 6 | CALLIDITAS THERAPEUTICS US INC. ($249.51) |
| 2023 | $57.25 | 1 | AstraZeneca Pharmaceuticals LP ($57.25) |
| 2022 | $470.42 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($129.21) |
| 2021 | $24.15 | 1 | Vifor Pharma, Inc. ($24.15) |
| 2020 | $514.74 | 2 | Fresenius USA Marketing, Inc. ($500.00) |
| 2019 | $14,873 | 28 | Fresenius USA Marketing, Inc. ($9,119) |
| 2018 | $17,281 | 30 | Fresenius USA Marketing, Inc. ($17,281) |
| 2017 | $8,590 | 21 | Fresenius USA Marketing, Inc. ($8,279) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $124.51 | General |
| Category: Nephrology | ||||||
| 10/15/2024 | Mozarc Medical US LLC | ARGYLE (Device) | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| Category: DIALYSIS CATHETERS | ||||||
| 09/11/2024 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $117.76 | General |
| 08/07/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $108.28 | General |
| Category: NEPHROLOGY | ||||||
| 03/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 04/25/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $57.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardio-renal | ||||||
| 11/16/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEPHROLOGY | ||||||
| 06/29/2022 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $107.63 | General |
| 03/23/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $108.58 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $4.22 | General |
| Category: Cardio-renal | ||||||
| 01/22/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Hyperkalemia | ||||||
| 09/23/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEPHROLOGY | ||||||
| 08/12/2020 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/11/2019 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $55.13 | General |
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $105.59 | General |
| Category: NEPHROLOGY | ||||||
| 08/16/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Nephrology | ||||||
| 07/30/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $1,945.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/30/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $250.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/16/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Consulting Fee | Cash or cash equivalent | $115.11 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/12/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $2,750.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/12/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $726.98 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 380 | 930 | $307,074 | $138,461 |
| 2022 | 9 | 393 | 980 | $285,202 | $131,502 |
| 2021 | 9 | 375 | 893 | $252,829 | $119,986 |
| 2020 | 11 | 411 | 912 | $244,456 | $95,124 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 33 | 268 | $202,072 | $80,748 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 267 | $48,060 | $27,918 | 58.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 94 | $23,500 | $14,252 | 60.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 17 | $10,319 | $4,265 | 41.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $7,980 | $3,933 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 46 | $5,290 | $3,371 | 63.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,700 | $2,495 | 43.8% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 11 | 171 | $3,883 | $1,387 | 35.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 27 | $270.00 | $92.07 | 34.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 36 | 236 | $177,944 | $72,812 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 250 | $45,000 | $26,500 | 58.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 90 | $22,500 | $13,679 | 60.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 18 | 22 | $13,354 | $5,296 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 58 | $6,670 | $4,217 | 63.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $7,220 | $3,613 | 50.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,900 | $3,178 | 46.1% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 18 | 254 | $5,334 | $2,112 | 39.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 28 | $280.00 | $95.92 | 34.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 26 | 202 | $152,308 | $61,079 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 141 | 231 | $41,580 | $25,091 | 60.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 73 | 142 | $35,500 | $21,783 | 61.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $8,740 | $4,219 | 48.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 33 | $3,795 | $2,243 | 59.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 29 | 38 | $2,850 | $2,152 | 75.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,900 | $1,780 | 45.6% |
About Dr. Beckie Michael, DO
Dr. Beckie Michael, DO is a Internal Medicine healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346272796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beckie Michael, DO has received a total of $42,387 in payments from pharmaceutical and medical device companies, with $575.16 received in 2024. These payments were reported across 94 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,500).
As a Medicare-enrolled provider, Michael has provided services to 1,559 Medicare beneficiaries, totaling 3,715 services with total Medicare billing of $485,073. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Nephrology
- Location Marlton, NJ
- Active Since 07/07/2006
- Last Updated 03/06/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346272796
Products in Payments
- Velphoro (Drug) $30,931
- Not Product Related (Medical Supply) $4,247
- TRIFERIC (Drug) $3,357
- LOKELMA (Drug) $2,114
- TARPEYO (Drug) $249.51
- JYNARQUE (Drug) $230.59
- ACE (Device) $154.18
- Veltassa (Drug) $143.30
- Kerendia (Drug) $129.21
- SAMSCA (Drug) $121.77
- BENLYSTA (Biological) $108.58
- XPHOZAH 30 MG (Drug) $108.28
- ARGYLE (Device) $75.00
- Vafseo (Drug) $24.61
- Rayaldee (Drug) $21.13
- AURYXIA (Drug) $14.74
- FABRY-DISEASE (Drug) $14.26
- SYSTEM ONE (Device) $10.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marlton
Dr. Minhaz Karim, Md, MD
Internal Medicine — Payments: $5,317
Joseph Moran, D.o, D.O
Internal Medicine — Payments: $3,800
Angel Rodis, Md, MD
Internal Medicine — Payments: $2,608
Dr. Brian Jaffe, Md, MD
Internal Medicine — Payments: $2,572
Dr. Michael Kleinman, D.o, D.O
Internal Medicine — Payments: $2,510
Stuart Gould, M.d, M.D
Internal Medicine — Payments: $2,419